MorphoSys AG Rings The Nasdaq Stock Market Opening Bell in Celebration of its IPO
MorphoSys AG (Nasdaq: MOR), a late-stage, biopharmaceutical company devoted to the development of innovative and differentiated therapies for patients suffering from serious diseases, visits the Nasdaq MarketSite in Times Square.
Format
JPEG
Source
Nasdaq, Inc.